Renaissance Technologies TEVA PHARMACEUTICAL INDS LTD ownership

TEVA PHARMACEUTICAL INDS LTD's ticker is TEVA and the CUSIP is 881624209. A total of 421 filers reported holding TEVA PHARMACEUTICAL INDS LTD in Q3 2022. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.

Renaissance Technologies ownership history of TEVA PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2022$35,024
+12.4%
4,340,000
+4.7%
0.05%
+35.1%
Q2 2022$31,170
+28.2%
4,144,963
+60.1%
0.04%
+27.6%
Q1 2022$24,312
+214.5%
2,589,163
+168.3%
0.03%
+190.0%
Q4 2021$7,731
+2115.2%
965,197
+2596.1%
0.01%
Q3 2021$349
-96.3%
35,800
-96.2%
0.00%
-100.0%
Q2 2021$9,369
-8.7%
946,363
-16.9%
0.01%
+20.0%
Q3 2020$10,264
-79.7%
1,139,163
-72.2%
0.01%
-77.3%
Q2 2020$50,448
+75.6%
4,091,463
+27.9%
0.04%
+57.1%
Q1 2020$28,727
+31.3%
3,199,032
+43.3%
0.03%
+64.7%
Q4 2019$21,874
-54.2%
2,231,996
-67.8%
0.02%
-57.5%
Q3 2019$47,738
-47.1%
6,938,663
-29.1%
0.04%
-50.0%
Q2 2019$90,325
+119.4%
9,786,063
+272.6%
0.08%
+116.2%
Q1 2019$41,178
-61.5%
2,626,163
-62.2%
0.04%
-68.4%
Q4 2018$107,045
+43.2%
6,941,985
+100.1%
0.12%
+51.9%
Q3 2018$74,737
-34.2%
3,469,663
-29.7%
0.08%
+24.2%
Q2 2018$113,574
+637.6%
4,937,826
+448.1%
0.06%
+264.7%
Q1 2018$15,397
-90.0%
900,963
-81.3%
0.02%
-92.1%
Q1 2017$154,602
+96.9%
4,817,763
+122.4%
0.22%
+74.2%
Q4 2016$78,513
-12.4%
2,165,863
+11.2%
0.12%
-21.5%
Q3 2016$89,626
+28.6%
1,947,963
+40.4%
0.16%
+18.8%
Q2 2016$69,707
+9.4%
1,387,763
+16.5%
0.13%
+9.9%
Q1 2016$63,744
+82.4%
1,191,263
+123.7%
0.12%
+59.2%
Q4 2015$34,953
-78.5%
532,500
-81.5%
0.08%
-80.4%
Q3 2015$162,535
+32.5%
2,878,763
+38.7%
0.39%
+39.1%
Q2 2015$122,678
+47.1%
2,075,763
+55.0%
0.28%
+56.7%
Q1 2015$83,417
+50.4%
1,338,963
+38.8%
0.18%
+32.8%
Q4 2014$55,478
+289.7%
964,663
+264.2%
0.13%
+243.6%
Q3 2014$14,236
-46.2%
264,863
-47.5%
0.04%
-37.1%
Q2 2014$26,454
+126.2%
504,663
+69.1%
0.06%
+100.0%
Q2 2013$11,696298,3630.03%